Table 1.
Baseline characteristics of COVID-19 patients.
| Variables | Total |
Non-Severe |
Severe |
P |
|---|---|---|---|---|
| n = 197 | n = 113 | n = 84 | ||
| Age, years (mean ± SD) | 54.0 ± 18.0 | 48.0 ± 16.6 | 62.1 ± 16.8 | <0.001 |
| Gender Female, n(%) | 89 (45.2) | 50 (44.2) | 39 (46.4) | 0.761 |
| Comorbidities | ||||
| Hypertension, n(%) | 87 (44.2) | 43 (38.1) | 44 (52.4) | 0.045 |
| Coronary artery disease, n(%) | 32 (16.2) | 10 (8.8) | 22 (26.2) | 0.002 |
| Diabetes mellitus, n(%) | 48 (24.4) | 17 (15.0) | 31 (36.9) | 0.001 |
| Hypothyroidism, n(%) | 11 (5.6) | 7 (6.2) | 4 (4.8) | 0.761 |
| Chronic renal failure, n(%) | 12 (6.1) | 7 (6.2) | 5 (6.0) | 1.000 |
| Malignancy, n(%) | 14 (7.1) | 5 (4.4) | 9 (10.7) | 0.156 |
| Chronic obstructive pulmonary disease, n(%) | 17 (8.6) | 6 (5.3) | 11 (13.1) | 0.095 |
| Asthma, n(%) | 10 (5.1) | 6 (5.3) | 4 (4.8) | 1.000 |
| Hepatitis B, n(%) | 3 (1.5) | 2 (1.8) | 1 (1.2) | 1.000 |
| Cirrhosis, n(%) | 3 (1.5) | 2 (1.8) | 1 (1.2) | 1.000 |
| Cerebrovascular disease, n(%) | 5 (2.5) | 2 (1.8) | 3 (3.6) | 0.653 |
| Clinical symptoms | ||||
| Cough, n(%) | 93 (47.2) | 50 (44.2) | 43 (48.8) | 0.334 |
| Fever, n(%) | 70 (35.5) | 42 (37.2) | 28 (33.3) | 0.578 |
| Dyspnea, n(%) | 56 (28.4) | 24 (21.2) | 32 (38.1) | 0.015 |
| Headache, n(%) | 18 (9.1) | 15 (13.3) | 3 (3.6) | 0.037 |
| Pharyngalgia, n(%) | 21 (10.7) | 17 (15.0) | 4 (4.8) | 0.038 |
| Fatigue, n(%) | 43 (21.8) | 29 (25.7) | 14 (16.7) | 0.181 |
| Anosmia/Hyposmia, n(%) | 4 (2.0) | 4 (3.5) | 0 (0) | 0.137 |
| Dysgeusia, n(%) | 4 (2.0) | 3 (2.7) | 1 (1.2) | 0.638 |
| Length of hospital stay, day (median, IQR) | 8 (5–11) | 6 (5–8) | 10 (8–15) | <0.001 |
| Death, n(%) | 8 (4.1) | 0 (0) | 8 (9.5) | <0.001 |
Abbr: n, number; IQR, interquartile range; SD, standard deviation.
Statistically significant P values are shown in bold.